Page 5 - Johnson Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab)The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European Commission Approvability of AVT02 and AVT04 in the U.S. now pending satisfactory US Food

/PRNewswire/ -- The "Global Diaper (Adult and Baby Diaper) Market: Insights & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering....

Homeowners with low mortgage rates aren't the only ones trapped by high-interest loans. So are mobile home park investors. Some plunged in anyway.

Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The

The global market for treating dry eye syndrome is poised for significant expansion, with an estimated valuation of US$ 4.80 Billion in 2022. This growth is expected to continue on a robust trajectory, with a healthy compound annual growth rate (CAGR) of 7.0% projected between 2022 and 2032. By the conclusion of 203...